Anticancer agent 260

Anticanceragent 260 is an orally bioavailable small molecule demonstrating in vitro antiproliferative activity against HCT-116, MIA-PaCa2, and MDA-MB231 cancer cell lines. It also exhibits in vivo relevant properties including analgesic and anti-inflammatory effects, alongside documented induction of ulcer formation and lipid peroxidation in research models.